Springer Nature
Nature Cancer
,  volume 5 ,  issue 12 ,  pages 1788

Overcoming immunoevasion in MHC class I-deficient cancers

Publication type: Journal Article
Publication date: 2024-12-17
Springer Nature
scimago Q1
wos Q1
SJR: 11.941
CiteScore: 34.2
Impact factor: 28.5
ISSN: 26621347

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Danelli L. Overcoming immunoevasion in MHC class I-deficient cancers // Nature Cancer. 2024. Vol. 5. No. 12. p. 1788.
GOST all authors (up to 50) Copy
Danelli L. Overcoming immunoevasion in MHC class I-deficient cancers // Nature Cancer. 2024. Vol. 5. No. 12. p. 1788.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s43018-024-00852-8
UR - https://www.nature.com/articles/s43018-024-00852-8
TI - Overcoming immunoevasion in MHC class I-deficient cancers
T2 - Nature Cancer
AU - Danelli, Luca
PY - 2024
DA - 2024/12/17
PB - Springer Nature
SP - 1788
IS - 12
VL - 5
PMID - 39690216
SN - 2662-1347
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Danelli,
author = {Luca Danelli},
title = {Overcoming immunoevasion in MHC class I-deficient cancers},
journal = {Nature Cancer},
year = {2024},
volume = {5},
publisher = {Springer Nature},
month = {dec},
url = {https://www.nature.com/articles/s43018-024-00852-8},
number = {12},
pages = {1788},
doi = {10.1038/s43018-024-00852-8}
}
MLA
Cite this
MLA Copy
Danelli, Luca. “Overcoming immunoevasion in MHC class I-deficient cancers.” Nature Cancer, vol. 5, no. 12, Dec. 2024, p. 1788. https://www.nature.com/articles/s43018-024-00852-8.